The Preventable Vaccines market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Preventable Vaccines size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Preventable Vaccines market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Preventable Vaccines market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Adult Preventable Vaccines
Pediatric Preventable Vaccines
Market segment by Application can be divided into
Bacterial Diseases
Virus Diseases
The key market players for global Preventable Vaccines market are listed below:
GlaxoSmithKline
Merck
Novartis
Pfizer
Sanofi
Takeda Pharmaceutical
Abbott
Roche
AstraZeneca
Mitsubishi Tanabe Pharma
Lupin
Serum Institute of India
LG Life Sciences
S K Chemicals
Shenzhen Kangtai Biological Products
Sinovac Biotech
Janssen Pharmaceuticals
Crucell
Bavarian Nordic
Baxter
Bharat Biotech
Dynavax
Bausch Health
Protein Sciences
Panacea Biotec
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Preventable Vaccines Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Preventable Vaccines Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Adult Preventable Vaccines
1.2.3 Pediatric Preventable Vaccines
1.3 Market Analysis by Application
1.3.1 Overview: Global Preventable Vaccines Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Bacterial Diseases
1.3.3 Virus Diseases
1.4 Global Preventable Vaccines Market Size & Forecast
1.4.1 Global Preventable Vaccines Sales in Value (2016-2026))
1.4.2 Global Preventable Vaccines Sales in Volume (2016-2026)
1.4.3 Global Preventable Vaccines Price by Type (2016-2026) & (USD/Unit)
1.5 Global Preventable Vaccines Production Capacity Analysis
1.5.1 Global Preventable Vaccines Total Production Capacity (2016-2026)
1.5.2 Global Preventable Vaccines Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Preventable Vaccines Market Drivers
1.6.2 Preventable Vaccines Market Restraints
1.6.3 Preventable Vaccines Trends Analysis
2 Manufacturers Profiles
2.1 GlaxoSmithKline
2.1.1 GlaxoSmithKline Details
2.1.2 GlaxoSmithKline Major Business
2.1.3 GlaxoSmithKline Preventable Vaccines Product and Services
2.1.4 GlaxoSmithKline Preventable Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Merck
2.2.1 Merck Details
2.2.2 Merck Major Business
2.2.3 Merck Preventable Vaccines Product and Services
2.2.4 Merck Preventable Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Novartis
2.3.1 Novartis Details
2.3.2 Novartis Major Business
2.3.3 Novartis Preventable Vaccines Product and Services
2.3.4 Novartis Preventable Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Pfizer
2.4.1 Pfizer Details
2.4.2 Pfizer Major Business
2.4.3 Pfizer Preventable Vaccines Product and Services
2.4.4 Pfizer Preventable Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 Sanofi
2.5.1 Sanofi Details
2.5.2 Sanofi Major Business
2.5.3 Sanofi Preventable Vaccines Product and Services
2.5.4 Sanofi Preventable Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 Takeda Pharmaceutical
2.6.1 Takeda Pharmaceutical Details
2.6.2 Takeda Pharmaceutical Major Business
2.6.3 Takeda Pharmaceutical Preventable Vaccines Product and Services
2.6.4 Takeda Pharmaceutical Preventable Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 Abbott
2.7.1 Abbott Details
2.7.2 Abbott Major Business
2.7.3 Abbott Preventable Vaccines Product and Services
2.7.4 Abbott Preventable Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.8 Roche
2.8.1 Roche Details
2.8.2 Roche Major Business
2.8.3 Roche Preventable Vaccines Product and Services
2.8.4 Roche Preventable Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.9 AstraZeneca
2.9.1 AstraZeneca Details
2.9.2 AstraZeneca Major Business
2.9.3 AstraZeneca Preventable Vaccines Product and Services
2.9.4 AstraZeneca Preventable Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.10 Mitsubishi Tanabe Pharma
2.10.1 Mitsubishi Tanabe Pharma Details
2.10.2 Mitsubishi Tanabe Pharma Major Business
2.10.3 Mitsubishi Tanabe Pharma Preventable Vaccines Product and Services
2.10.4 Mitsubishi Tanabe Pharma Preventable Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.11 Lupin
2.11.1 Lupin Details
2.11.2 Lupin Major Business
2.11.3 Lupin Preventable Vaccines Product and Services
2.11.4 Lupin Preventable Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.12 Serum Institute of India
2.12.1 Serum Institute of India Details
2.12.2 Serum Institute of India Major Business
2.12.3 Serum Institute of India Preventable Vaccines Product and Services
2.12.4 Serum Institute of India Preventable Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.13 LG Life Sciences
2.13.1 LG Life Sciences Details
2.13.2 LG Life Sciences Major Business
2.13.3 LG Life Sciences Preventable Vaccines Product and Services
2.13.4 LG Life Sciences Preventable Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.14 S K Chemicals
2.14.1 S K Chemicals Details
2.14.2 S K Chemicals Major Business
2.14.3 S K Chemicals Preventable Vaccines Product and Services
2.14.4 S K Chemicals Preventable Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.15 Shenzhen Kangtai Biological Products
2.15.1 Shenzhen Kangtai Biological Products Details
2.15.2 Shenzhen Kangtai Biological Products Major Business
2.15.3 Shenzhen Kangtai Biological Products Preventable Vaccines Product and Services
2.15.4 Shenzhen Kangtai Biological Products Preventable Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.16 Sinovac Biotech
2.16.1 Sinovac Biotech Details
2.16.2 Sinovac Biotech Major Business
2.16.3 Sinovac Biotech Preventable Vaccines Product and Services
2.16.4 Sinovac Biotech Preventable Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.17 Janssen Pharmaceuticals
2.17.1 Janssen Pharmaceuticals Details
2.17.2 Janssen Pharmaceuticals Major Business
2.17.3 Janssen Pharmaceuticals Preventable Vaccines Product and Services
2.17.4 Janssen Pharmaceuticals Preventable Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.18 Crucell
2.18.1 Crucell Details
2.18.2 Crucell Major Business
2.18.3 Crucell Preventable Vaccines Product and Services
2.18.4 Crucell Preventable Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.19 Bavarian Nordic
2.19.1 Bavarian Nordic Details
2.19.2 Bavarian Nordic Major Business
2.19.3 Bavarian Nordic Preventable Vaccines Product and Services
2.19.4 Bavarian Nordic Preventable Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.20 Baxter
2.20.1 Baxter Details
2.20.2 Baxter Major Business
2.20.3 Baxter Preventable Vaccines Product and Services
2.20.4 Baxter Preventable Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.21 Bharat Biotech
2.21.1 Bharat Biotech Details
2.21.2 Bharat Biotech Major Business
2.21.3 Bharat Biotech Preventable Vaccines Product and Services
2.21.4 Bharat Biotech Preventable Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.22 Dynavax
2.22.1 Dynavax Details
2.22.2 Dynavax Major Business
2.22.3 Dynavax Preventable Vaccines Product and Services
2.22.4 Dynavax Preventable Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.23 Bausch Health
2.23.1 Bausch Health Details
2.23.2 Bausch Health Major Business
2.23.3 Bausch Health Preventable Vaccines Product and Services
2.23.4 Bausch Health Preventable Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.24 Protein Sciences
2.24.1 Protein Sciences Details
2.24.2 Protein Sciences Major Business
2.24.3 Protein Sciences Preventable Vaccines Product and Services
2.24.4 Protein Sciences Preventable Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.25 Panacea Biotec
2.25.1 Panacea Biotec Details
2.25.2 Panacea Biotec Major Business
2.25.3 Panacea Biotec Preventable Vaccines Product and Services
2.25.4 Panacea Biotec Preventable Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Preventable Vaccines Sales by Manufacturer
3.1 Global Preventable Vaccines Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Preventable Vaccines Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Preventable Vaccines
3.4 Market Concentration Rate
3.4.1 Top 3 Preventable Vaccines Manufacturer Market Share
3.4.2 Top 6 Preventable Vaccines Manufacturer Market Share
3.5 Global Preventable Vaccines Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Preventable Vaccines Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Preventable Vaccines Market Size by Region
4.1.1 Global Preventable Vaccines Sales in Volume by Region (2016-2026)
4.1.2 Global Preventable Vaccines Revenue by Region (2016-2026)
4.2 North America Preventable Vaccines Revenue (2016-2026)
4.3 Europe Preventable Vaccines Revenue (2016-2026)
4.4 Asia-Pacific Preventable Vaccines Revenue (2016-2026)
4.5 South America Preventable Vaccines Revenue (2016-2026)
4.6 Middle East and Africa Preventable Vaccines Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Preventable Vaccines Sales in Volume by Type (2016-2026)
5.2 Global Preventable Vaccines Revenue by Type (2016-2026)
5.3 Global Preventable Vaccines Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Preventable Vaccines Sales in Volume by Application (2016-2026)
6.2 Global Preventable Vaccines Revenue by Application (2016-2026)
6.3 Global Preventable Vaccines Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Preventable Vaccines Sales by Type (2016-2026)
7.2 North America Preventable Vaccines Sales by Application (2016-2026)
7.3 North America Preventable Vaccines Market Size by Country
7.3.1 North America Preventable Vaccines Sales in Volume by Country (2016-2026)
7.3.2 North America Preventable Vaccines Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Preventable Vaccines Sales by Type (2016-2026)
8.2 Europe Preventable Vaccines Sales by Application (2016-2026)
8.3 Europe Preventable Vaccines Market Size by Country
8.3.1 Europe Preventable Vaccines Sales in Volume by Country (2016-2026)
8.3.2 Europe Preventable Vaccines Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Preventable Vaccines Sales by Type (2016-2026)
9.2 Asia-Pacific Preventable Vaccines Sales by Application (2016-2026)
9.3 Asia-Pacific Preventable Vaccines Market Size by Region
9.3.1 Asia-Pacific Preventable Vaccines Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Preventable Vaccines Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Preventable Vaccines Sales by Type (2016-2026)
10.2 South America Preventable Vaccines Sales by Application (2016-2026)
10.3 South America Preventable Vaccines Market Size by Country
10.3.1 South America Preventable Vaccines Sales in Volume by Country (2016-2026)
10.3.2 South America Preventable Vaccines Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Preventable Vaccines Sales by Type (2016-2026)
11.2 Middle East & Africa Preventable Vaccines Sales by Application (2016-2026)
11.3 Middle East & Africa Preventable Vaccines Market Size by Country
11.3.1 Middle East & Africa Preventable Vaccines Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Preventable Vaccines Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Preventable Vaccines Typical Distributors
12.3 Preventable Vaccines Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
List of Tables
Table 1. Global Preventable Vaccines Revenue by Type, (USD Million), 2021-2026
Table 2. Global Preventable Vaccines Revenue by Application, (USD Million), 2021-2026
Table 3. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 4. GlaxoSmithKline Major Business
Table 5. GlaxoSmithKline Preventable Vaccines Product and Services
Table 6. GlaxoSmithKline Preventable Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Merck Basic Information, Manufacturing Base and Competitors
Table 8. Merck Major Business
Table 9. Merck Preventable Vaccines Product and Services
Table 10. Merck Preventable Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Novartis Basic Information, Manufacturing Base and Competitors
Table 12. Novartis Major Business
Table 13. Novartis Preventable Vaccines Product and Services
Table 14. Novartis Preventable Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Pfizer Basic Information, Manufacturing Base and Competitors
Table 16. Pfizer Major Business
Table 17. Pfizer Preventable Vaccines Product and Services
Table 18. Pfizer Preventable Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Sanofi Basic Information, Manufacturing Base and Competitors
Table 20. Sanofi Major Business
Table 21. Sanofi Preventable Vaccines Product and Services
Table 22. Sanofi Preventable Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Takeda Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 24. Takeda Pharmaceutical Major Business
Table 25. Takeda Pharmaceutical Preventable Vaccines Product and Services
Table 26. Takeda Pharmaceutical Preventable Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Abbott Basic Information, Manufacturing Base and Competitors
Table 28. Abbott Major Business
Table 29. Abbott Preventable Vaccines Product and Services
Table 30. Abbott Preventable Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Roche Basic Information, Manufacturing Base and Competitors
Table 32. Roche Major Business
Table 33. Roche Preventable Vaccines Product and Services
Table 34. Roche Preventable Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 36. AstraZeneca Major Business
Table 37. AstraZeneca Preventable Vaccines Product and Services
Table 38. AstraZeneca Preventable Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Mitsubishi Tanabe Pharma Basic Information, Manufacturing Base and Competitors
Table 40. Mitsubishi Tanabe Pharma Major Business
Table 41. Mitsubishi Tanabe Pharma Preventable Vaccines Product and Services
Table 42. Mitsubishi Tanabe Pharma Preventable Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Lupin Basic Information, Manufacturing Base and Competitors
Table 44. Lupin Major Business
Table 45. Lupin Preventable Vaccines Product and Services
Table 46. Lupin Preventable Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. Serum Institute of India Basic Information, Manufacturing Base and Competitors
Table 48. Serum Institute of India Major Business
Table 49. Serum Institute of India Preventable Vaccines Product and Services
Table 50. Serum Institute of India Preventable Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 51. LG Life Sciences Basic Information, Manufacturing Base and Competitors
Table 52. LG Life Sciences Major Business
Table 53. LG Life Sciences Preventable Vaccines Product and Services
Table 54. LG Life Sciences Preventable Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 55. S K Chemicals Basic Information, Manufacturing Base and Competitors
Table 56. S K Chemicals Major Business
Table 57. S K Chemicals Preventable Vaccines Product and Services
Table 58. S K Chemicals Preventable Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 59. Shenzhen Kangtai Biological Products Basic Information, Manufacturing Base and Competitors
Table 60. Shenzhen Kangtai Biological Products Major Business
Table 61. Shenzhen Kangtai Biological Products Preventable Vaccines Product and Services
Table 62. Shenzhen Kangtai Biological Products Preventable Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 63. Sinovac Biotech Basic Information, Manufacturing Base and Competitors
Table 64. Sinovac Biotech Major Business
Table 65. Sinovac Biotech Preventable Vaccines Product and Services
Table 66. Sinovac Biotech Preventable Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 67. Janssen Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 68. Janssen Pharmaceuticals Major Business
Table 69. Janssen Pharmaceuticals Preventable Vaccines Product and Services
Table 70. Janssen Pharmaceuticals Preventable Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 71. Crucell Basic Information, Manufacturing Base and Competitors
Table 72. Crucell Major Business
Table 73. Crucell Preventable Vaccines Product and Services
Table 74. Crucell Preventable Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 75. Bavarian Nordic Basic Information, Manufacturing Base and Competitors
Table 76. Bavarian Nordic Major Business
Table 77. Bavarian Nordic Preventable Vaccines Product and Services
Table 78. Bavarian Nordic Preventable Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 79. Baxter Basic Information, Manufacturing Base and Competitors
Table 80. Baxter Major Business
Table 81. Baxter Preventable Vaccines Product and Services
Table 82. Baxter Preventable Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 83. Bharat Biotech Basic Information, Manufacturing Base and Competitors
Table 84. Bharat Biotech Major Business
Table 85. Bharat Biotech Preventable Vaccines Product and Services
Table 86. Bharat Biotech Preventable Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 87. Dynavax Basic Information, Manufacturing Base and Competitors
Table 88. Dynavax Major Business
Table 89. Dynavax Preventable Vaccines Product and Services
Table 90. Dynavax Preventable Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 91. Bausch Health Basic Information, Manufacturing Base and Competitors
Table 92. Bausch Health Major Business
Table 93. Bausch Health Preventable Vaccines Product and Services
Table 94. Bausch Health Preventable Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 95. Protein Sciences Basic Information, Manufacturing Base and Competitors
Table 96. Protein Sciences Major Business
Table 97. Protein Sciences Preventable Vaccines Product and Services
Table 98. Protein Sciences Preventable Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 99. Panacea Biotec Basic Information, Manufacturing Base and Competitors
Table 100. Panacea Biotec Major Business
Table 101. Panacea Biotec Preventable Vaccines Product and Services
Table 102. Panacea Biotec Preventable Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 103. Global Preventable Vaccines Sales by Manufacturer (2019-2021e) & (K Units)
Table 104. Global Preventable Vaccines Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 105. Market Position of Manufacturers in Preventable Vaccines, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 106. Global Preventable Vaccines Production Capacity by Company, (K Units): 2020 VS 2021
Table 107. Head Office and Preventable Vaccines Production Site of Key Manufacturer
Table 108. Global Preventable Vaccines Sales by Region (2016-2021e) & (K Units)
Table 109. Global Preventable Vaccines Sales by Region (2021-2026) & (K Units)
Table 110. Global Preventable Vaccines Revenue by Region (2016-2021e) & (USD Million)
Table 111. Global Preventable Vaccines Revenue by Region (2021-2026) & (USD Million)
Table 112. Global Preventable Vaccines Sales by Type (2016-2021e) & (K Units)
Table 113. Global Preventable Vaccines Sales by Type (2021-2026) & (K Units)
Table 114. Global Preventable Vaccines Revenue by Type (2016-2021e) & (USD Million)
Table 115. Global Preventable Vaccines Revenue by Type (2021-2026) & (USD Million)
Table 116. Global Preventable Vaccines Price by Type (2016-2021e) & (USD/Unit)
Table 117. Global Preventable Vaccines Price by Type (2021-2026) & (USD/Unit)
Table 118. Global Preventable Vaccines Sales by Application (2016-2021e) & (K Units)
Table 119. Global Preventable Vaccines Sales by Application (2021-2026) & (K Units)
Table 120. Global Preventable Vaccines Revenue by Application (2016-2021e) & (USD Million)
Table 121. Global Preventable Vaccines Revenue by Application (2021-2026) & (USD Million)
Table 122. Global Preventable Vaccines Price by Application (2016-2021e) & (USD/Unit)
Table 123. Global Preventable Vaccines Price by Application (2021-2026) & (USD/Unit)
Table 124. North America Preventable Vaccines Sales by Country (2016-2021e) & (K Units)
Table 125. North America Preventable Vaccines Sales by Country (2021-2026) & (K Units)
Table 126. North America Preventable Vaccines Revenue by Country (2016-2021e) & (USD Million)
Table 127. North America Preventable Vaccines Revenue by Country (2021-2026) & (USD Million)
Table 128. North America Preventable Vaccines Sales by Type (2016-2021e) & (K Units)
Table 129. North America Preventable Vaccines Sales by Type (2021-2026) & (K Units)
Table 130. North America Preventable Vaccines Sales by Application (2016-2021e) & (K Units)
Table 131. North America Preventable Vaccines Sales by Application (2021-2026) & (K Units)
Table 132. Europe Preventable Vaccines Sales by Country (2016-2021e) & (K Units)
Table 133. Europe Preventable Vaccines Sales by Country (2021-2026) & (K Units)
Table 134. Europe Preventable Vaccines Revenue by Country (2016-2021e) & (USD Million)
Table 135. Europe Preventable Vaccines Revenue by Country (2021-2026) & (USD Million)
Table 136. Europe Preventable Vaccines Sales by Type (2016-2021e) & (K Units)
Table 137. Europe Preventable Vaccines Sales by Type (2021-2026) & (K Units)
Table 138. Europe Preventable Vaccines Sales by Application (2016-2021e) & (K Units)
Table 139. Europe Preventable Vaccines Sales by Application (2021-2026) & (K Units)
Table 140. Asia-Pacific Preventable Vaccines Sales by Region (2016-2021e) & (K Units)
Table 141. Asia-Pacific Preventable Vaccines Sales by Region (2021-2026) & (K Units)
Table 142. Asia-Pacific Preventable Vaccines Revenue by Region (2016-2021e) & (USD Million)
Table 143. Asia-Pacific Preventable Vaccines Revenue by Region (2021-2026) & (USD Million)
Table 144. Asia-Pacific Preventable Vaccines Sales by Type (2016-2021e) & (K Units)
Table 145. Asia-Pacific Preventable Vaccines Sales by Type (2021-2026) & (K Units)
Table 146. Asia-Pacific Preventable Vaccines Sales by Application (2016-2021e) & (K Units)
Table 147. Asia-Pacific Preventable Vaccines Sales by Application (2021-2026) & (K Units)
Table 148. South America Preventable Vaccines Sales by Country (2016-2021e) & (K Units)
Table 149. South America Preventable Vaccines Sales by Country (2021-2026) & (K Units)
Table 150. South America Preventable Vaccines Revenue by Country (2016-2021e) & (USD Million)
Table 151. South America Preventable Vaccines Revenue by Country (2021-2026) & (USD Million)
Table 152. South America Preventable Vaccines Sales by Type (2016-2021e) & (K Units)
Table 153. South America Preventable Vaccines Sales by Type (2021-2026) & (K Units)
Table 154. South America Preventable Vaccines Sales by Application (2016-2021e) & (K Units)
Table 155. South America Preventable Vaccines Sales by Application (2021-2026) & (K Units)
Table 156. Middle East & Africa Preventable Vaccines Sales by Country (2016-2021e) & (K Units)
Table 157. Middle East & Africa Preventable Vaccines Sales by Country (2021-2026) & (K Units)
Table 158. Middle East & Africa Preventable Vaccines Revenue by Country (2016-2021e) & (USD Million)
Table 159. Middle East & Africa Preventable Vaccines Revenue by Country (2021-2026) & (USD Million)
Table 160. Middle East & Africa Preventable Vaccines Sales by Type (2016-2021e) & (K Units)
Table 161. Middle East & Africa Preventable Vaccines Sales by Type (2021-2026) & (K Units)
Table 162. Middle East & Africa Preventable Vaccines Sales by Application (2016-2021e) & (K Units)
Table 163. Middle East & Africa Preventable Vaccines Sales by Application (2021-2026) & (K Units)
Table 164. Direct Channel Pros & Cons
Table 165. Indirect Channel Pros & Cons
Table 166. Preventable Vaccines Typical Distributors
Table 167. Preventable Vaccines Typical Customers
List of Figures
Figure 1. Preventable Vaccines Picture
Figure 2. Global Preventable Vaccines Sales Market Share by Type in 2020
Figure 3. Adult Preventable Vaccines
Figure 4. Pediatric Preventable Vaccines
Figure 5. Global Preventable Vaccines Sales Market Share by Application in 2020
Figure 6. Bacterial Diseases
Figure 7. Virus Diseases
Figure 8. Global Preventable Vaccines Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 9. Global Preventable Vaccines Market Size and Forecast (2016-2026) & (USD Million)
Figure 10. United States Preventable Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 11. Canada Preventable Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 12. Mexico Preventable Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 13. Germany Preventable Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 14. France Preventable Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. United Kingdom Preventable Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. Russia Preventable Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. Italy Preventable Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. China Preventable Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. Japan Preventable Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. Korea Preventable Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. India Preventable Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. Southeast Asia Preventable Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. Australia Preventable Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Brazil Preventable Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Egypt Preventable Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Saudi Arabia Preventable Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. South Africa Preventable Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Turkey Preventable Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Global Preventable Vaccines Sales (2016-2026) & (K Units)
Figure 30. Global Preventable Vaccines Production Capacity (2016-2026) & (K Units)
Figure 31. Global Preventable Vaccines Production Capacity by Geographic Region: 2020 VS 2021
Figure 32. Preventable Vaccines Market Drivers
Figure 33. Preventable Vaccines Market Restraints
Figure 34. Preventable Vaccines Market Trends
Figure 35. Global Preventable Vaccines Sales Market Share by Manufacturer in 2020
Figure 36. Global Preventable Vaccines Revenue Market Share by Manufacturer in 2020
Figure 37. Preventable Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 38. Top 3 Preventable Vaccines Manufacturer (Revenue) Market Share in 2020
Figure 39. Top 6 Preventable Vaccines Manufacturer (Revenue) Market Share in 2020
Figure 40. Global Preventable Vaccines Sales Market Share by Region (2016-2026)
Figure 41. Global Preventable Vaccines Revenue Market Share by Region (2016-2026)
Figure 42. North America Preventable Vaccines Revenue (2016-2026) & (USD Million)
Figure 43. Europe Preventable Vaccines Revenue (2016-2026) & (USD Million)
Figure 44. Asia-Pacific Preventable Vaccines Revenue (2016-2026) & (USD Million)
Figure 45. South America Preventable Vaccines Revenue (2016-2026) & (USD Million)
Figure 46. Middle East & Africa Preventable Vaccines Revenue (2016-2026) & (USD Million)
Figure 47. Global Preventable Vaccines Sales Market Share by Type (2016-2026)
Figure 48. Global Preventable Vaccines Revenue Market Share by Type (2016-2026)
Figure 49. Global Preventable Vaccines Price by Type (2016-2026) & (USD/Unit)
Figure 50. Global Preventable Vaccines Sales Market Share by Application (2016-2026)
Figure 51. Global Preventable Vaccines Revenue Market Share by Application (2016-2026)
Figure 52. Global Preventable Vaccines Price by Application (2016-2026) & (USD/Unit)
Figure 53. North America Preventable Vaccines Sales Market Share by Country (2016-2026)
Figure 54. North America Preventable Vaccines Revenue Market Share by Country (2016-2026)
Figure 55. North America Preventable Vaccines Sales Market Share by Type (2016-2026)
Figure 56. North America Preventable Vaccines Sales Market Share by Application (2016-2026)
Figure 57. Europe Preventable Vaccines Sales Market Share by Country (2016-2026)
Figure 58. Europe Preventable Vaccines Revenue Market Share by Country (2016-2026)
Figure 59. Europe Preventable Vaccines Sales Market Share by Type (2016-2026)
Figure 60. Europe Preventable Vaccines Sales Market Share by Application (2016-2026)
Figure 61. Asia-Pacific Preventable Vaccines Sales Market Share by Region (2016-2026)
Figure 62. Asia-Pacific Preventable Vaccines Revenue Market Share by Region (2016-2026)
Figure 63. Asia-Pacific Preventable Vaccines Sales Market Share by Region (2016-2026)
Figure 64. Asia-Pacific Preventable Vaccines Sales Market Share by Application (2016-2026)
Figure 65. South America Preventable Vaccines Sales Market Share by Country (2016-2026)
Figure 66. South America Preventable Vaccines Revenue Market Share by Country (2016-2026)
Figure 67. South America Preventable Vaccines Sales Market Share by Type (2016-2026)
Figure 68. South America Preventable Vaccines Sales Market Share by Application (2016-2026)
Figure 69. Middle East & Africa Preventable Vaccines Sales Market Share by Country (2016-2026)
Figure 70. Middle East & Africa Preventable Vaccines Revenue Market Share by Country (2016-2026)
Figure 71. Middle East & Africa Preventable Vaccines Sales Market Share by Type (2016-2026)
Figure 72. Middle East & Africa Preventable Vaccines Sales Market Share by Application (2016-2026)
Figure 73. Sales Channel: Direct Channel vs Indirect Channel
Figure 74. Methodology
Figure 75. Research Process and Data Source